Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 9/20 | 0.45 |
| ▸ | PDE4B | Q07343 | 8/20 | 0.45 |
| ▸ | PDE4C | Q08493 | 8/20 | 0.45 |
| ▸ | PDE4D | Q08499 | 8/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.45 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | BRD4 | O60885 | 1/20 | 0.39 |
| ▸ | BRD2 | P25440 | 1/20 | 0.39 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.39 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.39 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7809883 | 0.87 | ADORA2A (0.47) | PDE4APDE4BPDE4CPDE4DADORA2A | |
| SCHEMBL27762592 | 0.85 | PDE4A (0.41) | PDE4APDE4BPDE4CPDE4DADORA2A | |
| SCHEMBL9059983 | 0.84 | PDE4A (0.55) | PDE4APDE4BPDE4CPDE4DADORA2A | |
| SCHEMBL20969999 | 0.76 | SMN1; SMN2 (0.45) | PDE4APDE4BPDE4CPDE4DADORA2A | |
| SCHEMBL26248690 | 0.70 | ADORA2A (0.54) | PDE4APDE4BPDE4CPDE4DADORA2A | |
| SCHEMBL6272735 | 0.69 | PDE4A (0.59) | PDE4APDE4BPDE4CPDE4DADORA2A | |
| SCHEMBL8326031 | 0.69 | RXFP1 (0.39) | ADORA2AADORA2BGAA | |
| SCHEMBL6270755 | 0.69 | ADORA2B (0.46) | PDE4APDE4BPDE4CPDE4DADORA2A | |
| SCHEMBL19090437 | 0.68 | BRD4 (0.59) | PDE4APDE4BPDE4CPDE4DADORA2A | |
| SCHEMBL9586814 | 0.68 | PDE4A (0.55) | PDE4APDE4BPDE4CPDE4DADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210147502-A1 | RECOMBINANT CANCER THERAPEUTIC CYTOKINE | UNIV VIRGINIA COMMONWEALTH (US) | 2021-05-20 | — | — | US | disclosed |
| US-20200384135-A1 | CANCER IMAGING WITH THERAPY: THERANOSTICS | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2020-12-10 | — | — | US | disclosed |
| EP-3004153-B1 | RECOMBINANT CANCER THERAPEUTIC CYTOKINE | UNIV VIRGINIA COMMONWEALTH (US) | 2019-10-30 | — | — | EP | disclosed |
| US-10166300-B2 | Tripartite cancer theranostic nucleic acid constructs | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2019-01-01 | — | — | US | disclosed |
| US-20180305429-A1 | RECOMBINANT CANCER THERAPEUTIC CYTOKINE | UNIV VIRGINIA COMMONWEALTH (US) | 2018-10-25 | — | — | US | disclosed |
| US-9951114-B2 | Recombinant cancer therapeutic cytokine | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2018-04-24 | — | — | US | disclosed |
| EP-3003022-B1 | USE OF A TRUNCATED CCN1 PROMOTER FOR CANCER DIAGNOSTICS, THERAPEUTICS AND THERANOSTICS | UNIV VIRGINIA COMMONWEALTH (US) | 2017-11-22 | — | — | EP | disclosed |
| EP-3004872-B1 | MDA-9/SYNTENIN PROMOTER TO IMAGE AND TREAT METASTATIC CANCER CELLS | UNIV VIRGINIA COMMONWEALTH (US) | 2017-10-18 | — | — | EP | disclosed |
| US-9750823-B2 | Use of a truncated CCN1 promoter for cancer diagnostics, therapeutics and theranostics | UNIV VIRGINIA COMMONWEALTH (US) | 2017-09-05 | — | — | US | disclosed |
| US-9701985-B2 | mda-9/syntenin promoter to image and treat metastatic cancer cells | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2017-07-11 | — | — | US | disclosed |
| EP-3003022-A1 | USE OF A TRUNCATED CCN1 PROMOTER FOR CANCER DIAGNOSTICS, THERAPEUTICS AND THERANOSTICS | Virginia Commonwealth University (US) | 2016-04-13 | — | — | EP | disclosed |
| EP-3004153-A1 | RECOMBINANT CANCER THERAPEUTIC CYTOKINE | Virginia Commonwealth University (US) | 2016-04-13 | — | — | EP | disclosed |
| EP-3003393-A2 | TRIPARTITE CANCER THERANOSTIC NUCLEIC ACID CONSTRUCTS | The Johns Hopkins University (US) | 2016-04-13 | — | — | EP | disclosed |
| WO-2014209553-A1 | USE OF A TRUNCATED CCN1 PROMOTER FOR CANCER DIAGNOSTICS, THERAPEUTICS AND THERANOSTICS | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2014-12-31 | — | — | WO | disclosed |
| WO-2014197598-A2 | TRIPARTITE CANCER THERANOSTIC NUCLEIC ACID CONSTRUCTS | THE JOHNS HOPKINS UNIVERSITY (US) | 2014-12-11 | — | — | WO | disclosed |
| WO-2014197535-A1 | RECOMBINANT CANCER THERAPEUTIC CYTOKINE | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2014-12-11 | — | — | WO | disclosed |
| US-20140227182-A1 | CANCER IMAGING WITH THERAPY: THERANOSTICS | THE JOHNS HOPKINS UNIVERSITY (US) | 2014-08-14 | — | — | US | disclosed |
| US-20130263296-A1 | CANCER IMAGING WITH THERAPY: THERANOSTICS | THE JOHNS HOPKINS UNIVERSITY (US) | 2013-10-03 | — | — | US | disclosed |
| EP-2633063-A2 | CANCER IMAGING WITH THERAPY: THERANOSTICS | Virginia Commonwealth University (US) | 2013-09-04 | — | — | EP | disclosed |
| WO-2012058522-A2 | CANCER IMAGING WITH THERAPY: THERANOSTICS | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2012-05-03 | — | — | WO | disclosed |